PHARMACOGENETICS OF ANTIDEPRESSANT RESPONSE AND REMISSION: TOWARD GENOTYPE-GUIDED PRESCRIBING IN MAJOR DEPRESSIVE DISORDER [ 2017 - 2020 ]

Research Grant

Researchers: Dr Chad Bousman (Principal investigator)

Brief description A “one-size fits all” approach to antidepressant pharmacotherapy in depression is suboptimal. Current technology and scientific data support the transition to a personalised approach to antidepressant pharmacotherapy. My research will (1) develop and test genetic based algorithms for their ability to predict antidepressant response and remission and (2) evaluate the clinical validity and utility of currently available algorithms in clinical practice.

Funding Amount $AUD 435,524.18

Funding Scheme Career Development Fellowships

Notes RD Wright Biomedical CDF